| Calcium | Approved Investigational Nutraceutical | CCND1 | 595 |
upregulated | Calcium results in increased expression of CCND1 mRNA | 11q13.3 | |
| Calcium | Approved Investigational Nutraceutical | CTNNB1 | 1499 |
upregulated | Calcium results in increased expression of CTNNB1 mRNA | 3p22.1 | |
| Calcium | Approved Investigational Nutraceutical | CYP1A1 | 1543 |
upregulated | [oltipraz results in increased abundance of Calcium] which results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Calcium | Approved Investigational Nutraceutical | EGR1 | 1958 |
upregulated | [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA | 5q31.2 | |
| Calcium | Approved Investigational Nutraceutical | IL6 | 3569 |
upregulated | Calcium results in increased expression of IL6 mRNA | 7p15.3 | |
| Calcium | Approved Investigational Nutraceutical | IVL | 3713 |
upregulated | Calcium results in increased expression of IVL mRNA | 1q21.3 | |
| Calcium | Approved Investigational Nutraceutical | KRT1 | 3848 |
upregulated | Calcium results in increased expression of KRT1 mRNA | 12q13.13 | |
| Calcium | Approved Investigational Nutraceutical | LOR | 4014 |
upregulated | Calcium results in increased expression of LOR mRNA | 1q21.3 | |
| Calcium | Approved Investigational Nutraceutical | SCGB1A1 | 7356 |
upregulated | Calcium results in increased expression of SCGB1A1 mRNA | 11q12.3 | |
| Calcium | Approved Investigational Nutraceutical | TGM1 | 7051 |
upregulated | Calcium results in increased expression of TGM1 mRNA | 14q12 | |
| Calcium | Approved Investigational Nutraceutical | WNT5A | 7474 |
upregulated | Calcium results in increased expression of WNT5A mRNA | 3p14.3 | |
| Calcium chloride | Approved Investigational | ALPL | 249 |
upregulated | Calcium Chloride results in increased expression of ALPL mRNA | 1p36.12 | |
| Calcium chloride | Approved Investigational | BGLAP | 632 |
upregulated | Calcium Chloride results in increased expression of BGLAP mRNA | 1q22 | |
| Calcium chloride | Approved Investigational | COL1A1 | 1277 |
upregulated | Calcium Chloride results in increased expression of COL1A1 mRNA | 17q21.33 | |
| Calcium chloride | Approved Investigational | PPID | 5481 |
upregulated | Calcium Chloride results in increased expression of PPID mRNA | 4q32.1 | |
| Calcium chloride | Approved Investigational | S100A8 | 6279 |
upregulated | Calcium Chloride results in increased expression of S100A8 mRNA | 1q21.3 | |
| Calcium chloride | Approved Investigational | S100A9 | 6280 |
upregulated | Calcium Chloride results in increased expression of S100A9 mRNA | 1q21.3 | |
| Calyculin A | Experimental | FOS | 2353 |
upregulated | calyculin A results in increased expression of FOS mRNA | 14q24.3 | |
| Calyculin A | Experimental | LIF | 3976 |
downregulated | calyculin A results in decreased expression of LIF mRNA | 22q12.2 | |
| Camptothecin | Investigational | AGRN | 375790 |
upregulated | Camptothecin results in increased expression of AGRN mRNA | 1p36.33 | |
| Camptothecin | Investigational | ANXA4 | 307 |
upregulated | Camptothecin results in increased expression of ANXA4 mRNA | 2p13.3 | |
| Camptothecin | Investigational | ATM | 472 |
downregulated | Camptothecin results in decreased expression of ATM mRNA | 11q22.3 | |
| Camptothecin | Investigational | BCL2 | 596 |
downregulated | Camptothecin results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Camptothecin | Investigational | BCL2 | 596 |
upregulated | Camptothecin results in increased expression of BCL2 mRNA | 18q21.33 | |
| Camptothecin | Investigational | BIRC5 | 332 |
downregulated | Camptothecin results in decreased expression of BIRC5 mRNA | 17q25.3 | |